| Acceptance No. | Drug Name | Active Ingredient | Dosage Form | Classification | Submission | Acceptance Date | Manufacturers | Manufacturers | Review Status | Status Date | View |
|---|---|---|---|---|---|---|---|---|---|---|---|
| CXSL2500425 | 重组人PD-L1/CD3 双抗溶瘤II型单纯疱疹病毒注射液（Vero细胞） | Biological Products(1) | New Drug Application | 2025-05-27 | Wuhan Binhui Biotechnology Co Ltd | view |